Skip to content

Infiltration Analgesia After Caesarean Section

Local Infiltration Analgesia for Postoperative Pain After Caesarean Section. A Prospective, Randomised, Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01094106
Enrollment
70
Registered
2010-03-26
Start date
2010-04-30
Completion date
2011-10-31
Last updated
2020-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative, Caesarean Section

Keywords

postoperative pain, infiltration analgesia, ropivacaine, Caesarean Section

Brief summary

Infiltration of a local anesthetic into the surgical wound is a simple method to strive to control postoperative pain after surgery. In the investigators institution, this method is used quite often. However, there is a controversy regarding the analgesic efficacy. Moreover, the cost of the single use elastomeric pump used with this procedure is clearly higher than the costs of other routinely used analgesic methods. According to the investigators observations, infiltration of a local anesthetic into the surgical wound after caesarean section seems to reduce the need for rescue analgesics. However, the scientific evidence of the efficacy of this technique is weak. The investigators decided to conduct a prospective, controlled, randomised, double blind trial on this topic. The hypothesis is that wound infiltration with local anesthetic will reduce postoperative pain and opioid consumption after caesarean section without major adverse effects.

Interventions

Postoperative wound infusion 2 ml/ h/ 48h

Postoperative wound infusion 2 ml/h/48h

Sponsors

North Karelia Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* volunteer * age over 18 years * spinal anesthesia * ASA 1-2 * no allergy to used medications * no medications which have effect on pain perception

Exclusion criteria

* patient's refusal to participate * marked systemic disease

Design outcomes

Primary

MeasureTime frameDescription
The Demand of Rescue Analgesics (Oxycodone)48 hoursThe amount of oxycodone required 48 hours after operation. Oxycodone was administered when the strength of pain is over 3 on numeric rating scale (NRS) 0-10.

Secondary

MeasureTime frameDescription
Strength of Pain on Numerical Rating Scale (NRS)48 hours, divided to five time intervals (0-6 h, 6-12 h, 12-24 h, 24-36 h and 36-48 h)Intensity of pain was recorded on a numerical rating scale (0-10), where higher scores mean more severe pain, during rest and when moving, for five time intervals (0-6 h, 6-12 h, 12-24 h, 24-36 h and 36-48 h); for each time interval, the highest recorded pain score was taken into account.
Postoperative Nausea and Vomiting (PONV)48 hoursThe numbers of patients with at least mild nausea at any time post-operatively.

Countries

Finland

Participant flow

Pre-assignment details

Three patients were excluded after recruitment and randomisation, for the following reasons: For one patient, an emergency operation was needed before the scheduled operation time; for one patient, the hospital pharmacy was unable to provide the study drug in time, and for one patient, no study drug was initiated because of communication errors.

Participants by arm

ArmCount
Ropivacaine 0,75%
Patients undergoing caesarean section under spinal anaesthesia Ropivacaine 0,75%: Postoperative wound infusion; initial bolus of 10 ml, followed by an infusion of 2 ml/ h/ 48h
33
NaCl 0,9%
Patients undergoing caesarean section under spinal anaesthesia NaCl 0,9%: Postoperative wound infusion; initial bolus of 10 ml, followed by an infusion of 2 ml/h/48h
34
Total67

Baseline characteristics

CharacteristicNaCl 0,9%TotalRopivacaine 0,75%
Age, Continuous30.9 years
STANDARD_DEVIATION 5.7
30.5 years
STANDARD_DEVIATION 5.7
30.1 years
STANDARD_DEVIATION 5.7
Dose of spinal bupivacaine, mg11.7 mg
STANDARD_DEVIATION 0.8
11.8 mg
STANDARD_DEVIATION 0.8
11.9 mg
STANDARD_DEVIATION 0.8
Height, cm162.9 cm
STANDARD_DEVIATION 6.4
162.6 cm
STANDARD_DEVIATION 6
162.4 cm
STANDARD_DEVIATION 5.7
Length of operation, min46.6 min
STANDARD_DEVIATION 13.8
47.0 min
STANDARD_DEVIATION 16.2
50.6 min
STANDARD_DEVIATION 18.3
Region of Enrollment
Finland
34 participants67 participants33 participants
Sex: Female, Male
Female
34 Participants67 Participants33 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants
Weight, kg80.6 kg
STANDARD_DEVIATION 17.2
78.2 kg
STANDARD_DEVIATION 15.2
75.8 kg
STANDARD_DEVIATION 12.6

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
1 / 332 / 34
serious
Total, serious adverse events
0 / 330 / 34

Outcome results

Primary

The Demand of Rescue Analgesics (Oxycodone)

The amount of oxycodone required 48 hours after operation. Oxycodone was administered when the strength of pain is over 3 on numeric rating scale (NRS) 0-10.

Time frame: 48 hours

ArmMeasureValue (MEAN)Dispersion
Ropivacaine 0,75%The Demand of Rescue Analgesics (Oxycodone)47.5 mgStandard Deviation 20.9
NaCl 0,9%The Demand of Rescue Analgesics (Oxycodone)57.8 mgStandard Deviation 29.4
Comparison: In a previous non-randomised study at our institution, the mean oxycodone consumption in the control group was 60.7 mg (SD, 22.2 mg) during the first 48 h after caesarean section. At α = 0.05, 31 patients would be needed in each group to achieve a power of 90% for detecting a 30% reduction in the need for rescue opioids, which we considered a clinically meaningful effect. We decided to enrol 70 patients. The final study population was 67 patients.p-value: 0.1t-test, 2 sided
Secondary

Postoperative Nausea and Vomiting (PONV)

The numbers of patients with at least mild nausea at any time post-operatively.

Time frame: 48 hours

ArmMeasureValue (NUMBER)
Ropivacaine 0,75%Postoperative Nausea and Vomiting (PONV)7 participants
NaCl 0,9%Postoperative Nausea and Vomiting (PONV)11 participants
p-value: 0.3Chi-squared
Secondary

Strength of Pain on Numerical Rating Scale (NRS)

Intensity of pain was recorded on a numerical rating scale (0-10), where higher scores mean more severe pain, during rest and when moving, for five time intervals (0-6 h, 6-12 h, 12-24 h, 24-36 h and 36-48 h); for each time interval, the highest recorded pain score was taken into account.

Time frame: 48 hours, divided to five time intervals (0-6 h, 6-12 h, 12-24 h, 24-36 h and 36-48 h)

ArmMeasureGroupValue (MEDIAN)
Ropivacaine 0,75%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores when moving, 0-6 h6.5 units on a scale
Ropivacaine 0,75%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores at rest, 0-6 h5 units on a scale
Ropivacaine 0,75%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores when moving, 6-12 h5 units on a scale
Ropivacaine 0,75%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores at rest, 24-36 h2.25 units on a scale
Ropivacaine 0,75%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores when moving, 12-24 h5 units on a scale
Ropivacaine 0,75%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores at rest, 6-12 h3 units on a scale
Ropivacaine 0,75%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores when moving, 24-36 h4.25 units on a scale
Ropivacaine 0,75%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores at rest, 36-48 h1 units on a scale
Ropivacaine 0,75%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores when moving, 36-48 h3 units on a scale
Ropivacaine 0,75%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores at rest, 12-24 h3 units on a scale
NaCl 0,9%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores when moving, 36-48 h4 units on a scale
NaCl 0,9%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores at rest, 0-6 h6 units on a scale
NaCl 0,9%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores at rest, 12-24 h3 units on a scale
NaCl 0,9%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores at rest, 24-36 h3 units on a scale
NaCl 0,9%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores at rest, 36-48 h2 units on a scale
NaCl 0,9%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores when moving, 0-6 h7 units on a scale
NaCl 0,9%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores when moving, 6-12 h6 units on a scale
NaCl 0,9%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores when moving, 12-24 h5.75 units on a scale
NaCl 0,9%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores when moving, 24-36 h5 units on a scale
NaCl 0,9%Strength of Pain on Numerical Rating Scale (NRS)Highest recorded pain scores at rest, 6-12 h3.75 units on a scale
Comparison: Highest recorded pain scores at rest, 0-6 hp-value: 0.08Wilcoxon (Mann-Whitney)
Comparison: Highest recorded pain scores at rest, 6-12 hp-value: 0.86Wilcoxon (Mann-Whitney)
Comparison: Highest recorded pain scores at rest, 12-24 hp-value: 0.66Wilcoxon (Mann-Whitney)
Comparison: Highest recorded pain scores at rest, 24-36 hp-value: 0.79Wilcoxon (Mann-Whitney)
Comparison: Highest recorded pain scores at rest, 36-48 hp-value: 0.2Wilcoxon (Mann-Whitney)
Comparison: Highest recorded pain scores when moving, 0-6 hp-value: 0.36Wilcoxon (Mann-Whitney)
Comparison: Highest recorded pain scores when moving, 6-12 hp-value: 0.43Wilcoxon (Mann-Whitney)
Comparison: Highest recorded pain scores when moving, 12-24 hp-value: 0.68Wilcoxon (Mann-Whitney)
Comparison: Highest recorded pain scores when moving, 24-36 hp-value: 0.37Wilcoxon (Mann-Whitney)
Comparison: Highest recorded pain scores when moving, 36-48 hp-value: 0.06Wilcoxon (Mann-Whitney)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026